Bristol-Myers Squibb (BMY) earnings, Oct 29, 2026: EPS −17%, stock +1.8%
In brief
Bristol-Myers Squibb reported on Oct 29, 2026. Earnings per share changed −17% year over year, 22.9% above the estimate; revenue +7%. The stock opened with a +2.6% gap and closed the day +1.8% (Oct 30, 2026). The stock is now 8.0% below its 52-week high, +38.9% over 12 months. Next report: Feb 4, 2027.
EPS vs estimate+22.9%
EPS, YoY−17%
Revenue, YoY+7%
Gap · day+2.6% · +1.8%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 30, 2026 | −0.6% | +2.8% |
| Oct 29, 2026 | +2.6% | +1.8% |
Next-quarter estimates, ratings and the BMY chart are in the terminal.
Open the terminalFAQ
When is Bristol-Myers Squibb's next earnings report?
Feb 4, 2027. The date comes from daily data and is corrected if the company moves it.
How did Bristol-Myers Squibb stock react to the report?
Opening gap +2.6%, day's result +1.8%.
Did Bristol-Myers Squibb's earnings grow?
Earnings per share fell 17% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.